United Therapeutics Company Profile

10:44 EDT 19th March 2019 | BioPortfolio

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. In these segments, United Therapeutics is actively developing four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine. At United Therapeutics, we find tremendous inspiration for our work and view our products as being new beginnings for patients and doctors, with quality of life as our utmost therapeutic goal. The theme of United Therapeutics is "Medicines for Life" because all of our therapeutics address life-threatening illnesses.


1110 Spring Street
Silver Spring
United States of America


Phone: 301 608 9292
Fax: 301.608.9291

News Articles [1117 Associated News Articles listed on BioPortfolio]

United Therapeutics to Co-Develop MannKind's Dry Powder Treprostinil for PAH

United Therapeutics has agreed to license and co-develop MannKind’s clinical-phase dry powder formulation of the pulmonary arterial hypertension (PAH) treatment treprostinil—the active ingredient ...

MannKind and United Therapeutics to advance dry powder treprostinil

US-based biopharmaceutical company MannKind has entered an exclusive licensing and collaboration agreement with United Therapeutics over a dry powder formulation...Read More... The post MannKind and U...

Arena Pharmaceuticals Snags $800 Million from United Therapeutics for a Phase III PAH Drug

United Therapeutics bets a significant amount of money on the potential commercialization of ralinepag.

Health Canada approves United Therapeutics' neuroblastoma drug

United Therapeutics' PrUnituxin, or dinutuximab, in combination with granulocyte-macrophage colony-stimulating factor, interl -More- 

United Therapeutics reaches $1.2bn licensing deal with Arena

Biotechnology company United Therapeutics has signed a licensing deal worth up to $1.2bn with biopharmaceutical firm Arena Pharmaceuticals for a...Read More... The post United Therapeutics reaches $1....

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - UTHR

NEW YORK, Dec. 3, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR). The ...

Collplant soars on pact with United Therapeutics

United Therapeutics will use Collplant's "biological ink" in producing 3D bioprinted lung transplants.

CollPlant, United Therapeutics sign deal for 3D printed lung transplants

The deal integrates recombinant human collagen (rhCollagen) and BioInk technology of CollPlant with United Therapeutics’ regenerative medicine and organ manufacturing capability. As per the agreemen...

PubMed Articles [1160 Associated PubMed Articles listed on BioPortfolio]

Regulatory Landscape in the United States.

State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data.

Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.

Repository corticotropin injection (RCI) has immune-modulatory and anti-inflammatory effects and is approved for multiple indications, including severe and acute chronic allergic and inflammatory proc...

Liver fat scores predict liver disease mortality in the United States population.

Fatty liver is a significant global public health burden, contributing to premature death.

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Clinical Trials [1374 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1999 Associated Companies listed on BioPortfolio]

United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious ...

CV Therapeutics, Inc.

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of ...

Wellstat Therapeutics Corporation

Wellstat Therapeutics™ Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therap...

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (Ig...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "United Therapeutics" on BioPortfolio

We have published hundreds of United Therapeutics news stories on BioPortfolio along with dozens of United Therapeutics Clinical Trials and PubMed Articles about United Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of United Therapeutics Companies in our database. You can also find out about relevant United Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record